Search Results - "Berg, Melody L."

  • Showing 1 - 10 results of 10
Refine Results
  1. 1

    Evaluation of Impact of Statin Use on Development of CPK Elevation During Daptomycin Therapy by Berg, Melody L., Estes, Lynn L., Dierkhising, Ross A., Curran, Brian, Enzler, Mark J.

    Published in The Annals of pharmacotherapy (01-03-2014)
    “…Background: Because both daptomycin and statins may increase creatine phosphokinase (CPK) levels, the manufacturer of daptomycin suggests considering holding…”
    Get full text
    Journal Article
  2. 2

    Is Abnormal Urine Protein/Osmolality Ratio Associated with Abnormal Renal Function in Patients Receiving Tenofovir Disoproxil Fumarate? by Marcelin, Jasmine R, Berg, Melody L, Tan, Eugene M, Amer, Hatem, Cummins, Nathan W, Rizza, Stacey A

    Published in PloS one (12-02-2016)
    “…Risk factors for and optimal surveillance of renal dysfunction in patients on tenofovir disoproxil fumarate (TDF) remain unclear. We investigated whether a…”
    Get full text
    Journal Article
  3. 3

    Efficacy of inactivated vaccines in patients treated with immunosuppressive drug therapy by Bemben, Nina M., Berg, Melody L.

    Published in Pharmacotherapy (01-04-2022)
    “…Inactivated vaccines are generally considered safe in immunocompromised patients but the ability of immunocompromised patients to generate an effective immune…”
    Get full text
    Journal Article
  4. 4

    Iatrogenic Cushing Syndrome Secondary to Ritonavir-Epidural Triamcinolone Interaction: An Illustrative Case and Review by Sadarangani, Sapna, Berg, Melody L., Mauck, William, Rizza, Stacey

    “…HIV positive patients on ritonavir-containing antiretroviral therapy (ART) can develop iatrogenic Cushing syndrome (IACS) and adrenal insufficiency as a result…”
    Get full text
    Journal Article
  5. 5

    Development and evaluation of a pharmacogenomics educational program for pharmacists by Formea, Christine M, Nicholson, Wayne T, McCullough, Kristen B, Berg, Kevin D, Berg, Melody L, Cunningham, Julie L, Merten, Julianna A, Ou, Narith N, Stollings, Joanna L

    “…Objectives. To evaluate hospital and outpatient pharmacists' pharmacogenomics knowledge before and 2 months after participating in a targeted, case-based…”
    Get full text
    Journal Article
  6. 6

    Efficacy of Ertapenem for Consolidation Therapy of Extended-Spectrum β-lactamase-Producing Gram-Negative Infections: A Case Series Report by Berg, Melody L, Crank, Christopher W, Philbrick, Alexander H, Hayden, Mary K

    Published in The Annals of pharmacotherapy (01-02-2008)
    “…Background: Infections caused by extended-spectrum β-lactamase (ESBL)-producing gram-negative organisms are becoming increasingly common and present…”
    Get full text
    Journal Article
  7. 7

    Assessment of the presence and quality of osteoporosis prevention education among at-risk internal medicine patients by Shulha, Jennifer A, Sviggum, Cortney B, O'Meara, John G, Berg, Melody L

    Published in The Consultant pharmacist (01-01-2014)
    “…Appropriate calcium and vitamin D intake for the prevention of osteoporosis represents an important component of osteoporosis prevention education (OPE). We…”
    Get more information
    Journal Article
  8. 8

    Is Abnormal Urine Protein/Osmolality Ratio Associated with Abnormal Renal Function in Patients Receiving Tenofovir Disoproxil Fumarate?: e0149562 by Marcelin, Jasmine R, Berg, Melody L, Tan, Eugene M, Amer, Hatem, Cummins, Nathan W, Rizza, Stacey A

    Published in PloS one (01-02-2016)
    “…Background Risk factors for and optimal surveillance of renal dysfunction in patients on tenofovir disoproxil fumarate (TDF) remain unclear. We investigated…”
    Get full text
    Journal Article
  9. 9

    Development and Evaluation of a Pharmacogenomics Educational Program for Pharmacists by mea, Christine M, Nicholson, Wayne T, McCullough, Kristen B, Berg, Kevin D, Berg, Melody L, Cunningham, Julie L, Merten, Julianna A, Ou, Narith N, Stollings, Joanna L

    “…To evaluate hospital and outpatient pharmacists' pharmacogenomics knowledge before and 2 months after participating in a targeted, case-based pharmacogenomics…”
    Get full text
    Journal Article
  10. 10